Geldof AA - Search Results

1

Targeted radiosensitization in prostate cancer.

Ghotra VP, Geldof AA, Danen EH. Ghotra VP, et al. Among authors: geldof aa. Curr Pharm Des. 2013;19(15):2819-28. doi: 10.2174/1381612811319150017. Curr Pharm Des. 2013. PMID: 23448469 Review.

2

Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line.

Geldof AA, Plaizier MA, Duivenvoorden I, Ringelberg M, Versteegh RT, Newling DW, Teule GJ. Geldof AA, et al. J Cancer Res Clin Oncol. 2003 Mar;129(3):175-82. doi: 10.1007/s00432-002-0412-8. Epub 2003 Mar 18. J Cancer Res Clin Oncol. 2003. PMID: 12684891

3

Radiosensitizing effect of cisplatin in prostate cancer cell lines.

Geldof AA, Slotman BJ. Geldof AA, et al. Cancer Lett. 1996 Mar 29;101(2):233-9. doi: 10.1016/0304-3835(96)04140-7. Cancer Lett. 1996. PMID: 8620475

4

COX-2 inhibitors act as radiosensitizer in tumor treatment.

Sminia P, Kuipers G, Geldof A, Lafleur V, Slotman B. Sminia P, et al. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S272-5. doi: 10.1016/s0753-3322(05)80044-7. Biomed Pharmacother. 2005. PMID: 16507391 Review.

5

Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer.

Jacobs JJ, Snackey C, Geldof AA, Characiejus D, Van Moorselaar RJ, Den Otter W. Jacobs JJ, et al. Among authors: geldof aa. Anticancer Res. 2014 Jun;34(6):2689-700. Anticancer Res. 2014. PMID: 24922629 Review.

6

Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells.

Geldof AA, de Rooij L, Versteegh RT, Newling DW, Teule GJ. Geldof AA, et al. J Nucl Med. 1999 Apr;40(4):667-71. J Nucl Med. 1999. PMID: 10210227 Free article.

7

Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.

Geldof AA, Kruit A, Newling DW, Slotman BJ. Geldof AA, et al. Anticancer Res. 1999 Jan-Feb;19(1A):505-8. Anticancer Res. 1999. PMID: 10226589

8

ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.

Oprea-Lager DE, Bijnsdorp IV, VAN Moorselaar RJ, VAN DEN Eertwegh AJ, Hoekstra OS, Geldof AA. Oprea-Lager DE, et al. Among authors: geldof aa. Anticancer Res. 2013 Feb;33(2):387-91. Anticancer Res. 2013. PMID: 23393328

9

Decay of γ-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells.

van Oorschot B, Hovingh SE, Rodermond H, Güçlü A, Losekoot N, Geldof AA, Barendsen GW, Stalpers LJ, Franken NA. van Oorschot B, et al. Among authors: geldof aa. Oncol Rep. 2013 Jun;29(6):2175-80. doi: 10.3892/or.2013.2364. Epub 2013 Mar 26. Oncol Rep. 2013. PMID: 23545587

10

A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting.

Hodzic J, Dingjan I, Maas MJ, van der Meulen-Muileman IH, de Menezes RX, Heukelom S, Verheij M, Gerritsen WR, Geldof AA, van Triest B, van Beusechem VW. Hodzic J, et al. Among authors: geldof aa. Radiat Oncol. 2015 Feb 27;10:55. doi: 10.1186/s13014-015-0355-2. Radiat Oncol. 2015. PMID: 25888875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page